Search results

    Filter results

  • Full text

  • Document type

  • Publication year

  • Organisation

Results: 210
Number of items: 210
  • Open Access
    Drion, C. M., van Scheppingen, J., Arena, A., Geijtenbeek, K. W., Kooijman, L., van Vliet, E. A., Aronica, E., & Gorter, J. A. (2018). Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo - in search of potential anti-epileptogenic strategies for temporal lobe epilepsy. Journal of neuroinflammation, 15, Article 212. https://doi.org/10.1186/s12974-018-1247-9
  • Open Access
    van Scheppingen, J., Mills, J. D., Zimmer, T. S., Broekaart, D. W. M., Iori, V., Bongaarts, A., Anink, J. J., Iyer, A. M., Korotkov, A., Jansen, F. E., van Hecke, W., Spliet, W. G., van Rijen, P. C., Baayen, J. C., Vezzani, A., van Vliet, E. A., & Aronica, E. (2018). miR147b: A novel key regulator of interleukin 1 beta-mediated inflammation in human astrocytes. GLIA, 66(5), 1082-1097. https://doi.org/10.1002/glia.23302
  • Open Access
    Ruffolo, G., Cifelli, P., Roseti, C., Thom, M., van Vliet, E. A., Limatola, C., Aronica, E., & Palma, E. (2018). A novel GABAergic dysfunction in human Dravet syndrome. Epilepsia, 59(11), 2106-2117. https://doi.org/10.1111/epi.14574
  • Open Access
    Broekaart, D. W. M., Anink, J. J., Baayen, J. C., Idema, S., de Vries, H. E., Aronica, E., Gorter, J. A., & van Vliet, E. A. (2018). Activation of the innate immune system is evident throughout epileptogenesis and is associated with blood-brain barrier dysfunction and seizure progression. Epilepsia, 59(10), 1931-1944. https://doi.org/10.1111/epi.14550
  • Open Access
    Iori, V. (2018). Epigenetic and pharmacological targeting of neuroinflammation as novel therapeutic interventions for epilepsy. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    van Scheppingen, J. G. M. (2018). Astrocytes as mediators of inflammation in epilepsy: focus on tuberous sclerosis complex. [Thesis, fully internal, Universiteit van Amsterdam].
  • Lapinlampi, N., Melin, E., Aronica, E., Bankstahl, J. P., Becker, A., Bernard, C., Gorter, J. A., Gröhn, O., Lipsanen, A., Lukasiuk, K., Löscher, W., Paananen, J., Ravizza, T., Roncon, P., Simonato, M., Vezzani, A., Kokaia, M., & Pitkänen, A. (2017). Common data elements and data management: Remedy to cure underpowered preclinical studies. Epilepsy Research, 129, 87-90. https://doi.org/10.1016/j.eplepsyres.2016.11.010
  • Aronica, E., Mühlebner, A., van Vliet, E. A., & Gorter, J. A. (2017). Characterization of pathology. In A. Pitkänen, P. S. Buckmaster, A. S. Galanopoulou, & S. L. Moshé (Eds.), Models of seizures and epilepsy (2nd ed., pp. 139-160). Academic Press. https://doi.org/10.1016/B978-0-12-804066-9.00011-0
  • Aronica, E., Bauer, S., Bozzi, Y., Caleo, M., Dingledine, R., Gorter, J. A., Henshall, D. C., Kaufer, D., Koh, S., Löscher, W., Louboutin, J.-P., Mishto, M., Norwood, B. A., Palma, E., Poulter, M. O., Terrone, G., Vezzani, A., & Kaminski, R. M. (2017). Neuroinflammatory targets and treatments for epilepsy validated in experimental models. Epilepsia, 58(S3), 27-38. https://doi.org/10.1111/epi.13783
  • Palma, E., Ruffolo, G., Cifelli, P., Roseti, C., van Vliet, E. A., & Aronica, E. (2017). Modulation of GABAA receptors in the treatment of epilepsy. Current pharmaceutical design, 23(37), 5563-5568. https://doi.org/10.2174/1381612823666170809100230
Page 7 of 21